ThouraniVH.EdelmanJJ.HolmesSDet al. The International Society for Minimally Invasive Cardiothoracic Surgery expert consensus statement on transcatheter and surgical aortic valve replacement in low- and intermediate-risk patients: a meta-analysis of randomized and propensity-matched studies. Innovations2021; 16: 3–16.33491539
2.
KaulS. Raising the evidentiary bar for guideline recommendations for TAVR: JACC review topic of the week. J Am Coll Cardiol2020; 76: 985–991.32819472
3.
MakkarRR.ThouraniVH.MackMJet al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med2020; 382: 799–809.31995682
4.
PibarotP.TernacleJ.JaberWAet al. Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial. J Am Coll Cardiol2020; 76: 1830–1843.33059828
5.
MackMJ,.LeonMB and PARTNER 3 Investigators. Two-year clinical and echocardiographic outcomes from the PARTNER 3 low-risk randomized trial. Paper presented at: American College of Cardiology Virtual Annual Scientific Session Together With World Congress of Cardiology (ACC 2020/WCC), March 292020.
6.
PibarotP.SalaunE.DahouAet al. Echocardiographic results of transcatheter versus surgical aortic valve replacement in low-risk patients: the PARTNER 3 trial. Circulation2020; 141: 1527–1537.32272848
7.
FujitaB.SchmidtT.BleizifferSet al. Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. Eur J Cardiothorac Surg2020; 57: 151–159.31199470
8.
BekeredjianR.SzaboG.BalabanÜmniyeet al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J2019; 40: 1323–1330.30445543
